Project Grant R01DA065187
- Federal Grant Award Summary The University of Miami received a $677,248 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a randomized controlled trial (RCT) testing the Comprehensive Telehealth Concierge (C-THR) model. The award, effective February 15, 2026, through December 31, 2030, focuses on improving HIV prevention and substance use disorder treatment engagement among individuals with histories...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded University of Miami $677,250 under the Drug Use and Addiction Research Programs (CFDA 93.279) on June 15, 2025, for development and testing of the Healthcare Empowerment and Advocacy for Recovery from Trafficking (HEART) intervention. The project, extending through May 31, 2028, addresses the intersecting public health emergencies of sex trafficking, opioid use disorder, and HIV epidemic by creating a peer-delivered brief...
- Federal Project Grant Award Summary The University of Miami, through its Office of Research Administration within the School of Medicine, received a Project Grant award of $109,076.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) on August 19, 2026. The award supports research investigating the mechanisms underlying cognitive impairment and neuropsychiatric disorders resulting from the combined effects of HIV infection and...
- Federal Project Grant Award Summary The University of South Carolina received a $631,513 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded February 15, 2026, with a completion date of December 31, 2030. This research initiative investigates modifiable factors affecting the HIV care continuum for people with HIV (PWH) experiencing concurrent substance use (SU) and mental health (MH) comorbidities. The project...
- Federal Grant Award Summary Wake Forest University Health Sciences received a $575,433 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning August 1, 2025, with a completion date of July 31, 2027. The award funds development and testing of "SHE CARES," a hybrid intervention combining contingency management (CM) and positive affect (PA) strategies designed to reduce HIV acquisition risk among...
- Federal Project Grant Award Summary The University of South Carolina received a $721,308 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective March 1, 2026, with a completion date of January 31, 2031. This award supports research examining the intersection of HIV and substance use disorder (SUD) through predictive modeling to identify current and emerging hotspots within affected communities. The research addresses a...
- Federal Project Grant Award Summary The University of California, San Diego has received a $1.57 million Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded August 1, 2025, with completion targeted for April 30, 2030. The grant funds a hybrid Type I trial titled "Breaking Barriers: Innovating HIV Elimination with Social Network Strategies and Routine Substance Use Screening," which will be conducted at...
- Federal Grant Award Summary The University of Washington received a $672,701 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective February 15, 2026, with a completion date of November 30, 2030. This research initiative focuses on implementing HIV screening and prevention services within low-barrier office-based opioid treatment (OBOT) programs at Harborview Medical Center in Seattle, Washington. The...
- Federal Grant Award Summary The University of Maryland, Baltimore received a $219,291 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 30, 2025, with a completion date of July 31, 2028. The award funds the INSPIRE (Integrated Services for PWID Using Person-Centered Interactions, Reach, and Engagement) study, an implementation science initiative designed to develop and evaluate an integrated...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $756,000 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective March 15, 2026, with completion targeted for February 28, 2029. The award supports formative research and pilot testing of implementation strategies designed to improve Pre-Exposure Prophylaxis (PrEP) engagement among hospitalized people who use substances (PWUS). The research...
The University of Miami's Office of Research Administration received a $793,508 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) on March 1, 2026, for a project period extending through January 31, 2031. The award funds STRIVES (Status-Neutral Tele-Health Concierge Intervention for People Who Use Drugs via Engagement Through Street Medicine), a comprehensive telehealth-based care model designed to increase access to HIV prevention, testing, and treatment services among people experiencing homelessness and substance use disorders. The intervention delivers status-neutral care through a combination of street medicine outreach, telehealth concierge services, and medication-assisted treatment (MAT) for opioid use disorder, alongside HIV prevention services including pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART). This research initiative addresses critical public health priorities outlined in the Ending the HIV Epidemic (EHE) initiative by developing and testing integrated service delivery models that simultaneously target the interconnected challenges of homelessness, substance use disorders, and HIV among vulnerable populations. The project builds upon previously completed pilot testing of the SN-THR model and aims to implement, scale, and sustain evidence-based interventions in real-world street medicine settings where individuals experience homelessness, thereby improving health outcomes and reducing barriers to care engagement among people who use drugs.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $793.5k | 2/26/26 |